ArticleCancer discovery2026

Discovery of BBO-11818, a Potent and Selective Noncovalent Inhibitor of (ON) and (OFF) KRAS with Activity against Multiple Oncogenic Mutants.

Carlos Stahlhut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.